We are live on ! Find out more
WHWK

Whitehawk Therapeutics
WHWK

33 hedge funds and large institutions have $324M invested in Whitehawk Therapeutics in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

535% more capital invested

Capital invested by funds: $51M → $324M (+$273M)

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

50% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 8

49.05% more ownership

Funds ownership: 4.25% → 53.3% (+49%)

21% less funds holding

Funds holding: 42 → 33 (-9)

47% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 19

Holders
33
Holders Change
-9
Holders Change %
-21.43%
% of All Funds
0.58%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.07%
New
10
Increased
12
Reduced
8
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ACP
Acuta Capital Partners
California
+$46.6M
2
ACA
Avoro Capital Advisors
New York
+$46.6M
3
VA
VR Adviser
New York
+$46.6M
4
VC
Vivo Capital
California
+$43.5M
5
BI
BVF Inc
California
+$35M

Top Sellers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
-$3.06M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$2.58M
3
PHP
Parkman Healthcare Partners
Connecticut
-$598K
4
JIC
Johnson Investment Counsel
Ohio
-$542K
5
BFM
Boothbay Fund Management
New York
-$353K
Name Holding Trade Value Shares
Change 		Change in
Stake
Osaic Holdings
26
Osaic Holdings
Arizona
$8K +$2.41K +79 +44%
UBS Group
27
UBS Group
Switzerland
$7K +$6.92K +227 +1,746%
NFG
28
Next Financial Group
Texas
$3K – – –
Morgan Stanley
29
Morgan Stanley
New York
$3K +$2.77K +91 New
Wells Fargo
30
Wells Fargo
California
$2K -$30 -1 -1%
TRCT
31
Tower Research Capital (TRC)
New York
$1K +$1.22K +40 New
PHP
32
Parkman Healthcare Partners
Connecticut
– -$598K -23,597 Closed
JIC
33
Johnson Investment Counsel
Ohio
– -$542K -21,369 Closed
BFM
34
Boothbay Fund Management
New York
– -$353K -13,912 Closed
State Street
35
State Street
Massachusetts
– -$216K -8,523 Closed
NRS
36
Neville Rodie & Shaw
New York
– -$169K -6,667 Closed
JGC
37
J. Goldman & Co
New York
– -$160K -6,300 Closed
AI
38
Atom Investors
Texas
– -$135K -5,333 Closed
SSA
39
Schonfeld Strategic Advisors
New York
– -$98K -3,873 Closed
Ameriprise
40
Ameriprise
Minnesota
– -$96K -3,796 Closed
Northern Trust
41
Northern Trust
Illinois
– -$94K -3,707 Closed
CL
42
CSS LLC
Illinois
– -$84K -3,333 Closed
VF
43
Virtu Financial
New York
– -$79K -3,125 Closed
Two Sigma Advisers
44
Two Sigma Advisers
New York
– -$34K -1,353 Closed
XT
45
XTX Topco
Cayman Islands
– -$29K -1,155 Closed
Dimensional Fund Advisors
46
Dimensional Fund Advisors
Texas
– -$26K -1,026 Closed
ECM
47
ExodusPoint Capital Management
New York
– -$25K -1,001 Closed
AWP
48
Ascent Wealth Partners
New York
– -$17K -667 Closed
LC
49
Lindbrook Capital
California
– -$8K -333 Closed
HWMA
50
Heritage Wealth Management (Arizona)
Arizona
– -$1K – –
1
2
3

WHWK Hedge Fund Activity: Q3 2021 in Review

33 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Whitehawk Therapeutics (WHWK) for Q3 2021, worth a combined $324M — up 535% from $51M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of WHWK and 10 opened new positions — a net loss of 9 holders — while 8 trimmed existing stakes and 12 added.

The largest buyer was Acuta Capital Partners, opening a new position worth an estimated $46.6M. The largest seller was Ikarian Capital, cutting an estimated $3.06M.

  • 33 institutional investors held Whitehawk Therapeutics (WHWK) as of Q3 2021, down from 42 in Q2 2021.
  • Funds reported $324M of Whitehawk Therapeutics stock for Q3 2021, up 535% quarter-over-quarter.
  • 10 funds opened new Whitehawk Therapeutics positions in Q3 2021 and 19 closed out, a net change of -9 holders.
  • The largest Whitehawk Therapeutics buyer in Q3 2021 was Acuta Capital Partners, an estimated $46.6M added.
  • The largest Whitehawk Therapeutics seller in Q3 2021 was Ikarian Capital, an estimated $3.06M sold.

Based on aggregated 13F filings for Q3 2021.